These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2104189)

  • 21. Immune cell signaling and gene transcription in human lupus: the time has come.
    Tsokos GC
    Int Rev Immunol; 2004; 23(3-4):221-4. PubMed ID: 15204085
    [No Abstract]   [Full Text] [Related]  

  • 22. IL-2 enhancing factor(s) in B cell supernatants from patients with rheumatoid arthritis or systemic lupus erythematosus.
    Tomura K; Kang H; Mitamura K; Takei M; Karasaki M; Koyasu S; Sawada S
    Tohoku J Exp Med; 1989 Nov; 159(3):171-83. PubMed ID: 2623661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B-cell and T-cell function in systemic lupus erythematosus.
    Via CS; Handwerger BS
    Curr Opin Rheumatol; 1993 Sep; 5(5):570-4. PubMed ID: 7691138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basophils and nephritis in lupus.
    Kaveri SV; Mouthon L; Bayry J
    N Engl J Med; 2010 Sep; 363(11):1080-2. PubMed ID: 20825323
    [No Abstract]   [Full Text] [Related]  

  • 25. Familial occurrence of impaired interleukin-2 activity and increased peripheral blood B cells actively secreting immunoglobulins in systemic lupus erythematosus.
    Sakane T; Murakawa Y; Suzuki N; Ueda Y; Tsuchida T; Takada S; Yamauchi Y; Tsunematsu T
    Am J Med; 1989 Apr; 86(4):385-90. PubMed ID: 2784626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytomegalovirus aggravates the autoimmune phenomenon in systemic autoimmune diseases.
    Janahi EMA; Das S; Bhattacharya SN; Haque S; Akhter N; Jawed A; Wahid M; Mandal RK; Lohani M; Areeshi MY; Ramachandran VG; Almalki S; Dar SA
    Microb Pathog; 2018 Jul; 120():132-139. PubMed ID: 29704668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Studies of the mechanisms of human B-cell activation. II. The role of resting B-cell abnormalities in the pathogenesis of systemic lupus erythematosus].
    Ueda Y; Sakane T; Suzuki N; Takada S; Murakawa Y; Tsunematsu T; Niwa Y; Tsuchiya T
    Ryumachi; 1985 Feb; 25(1):8-14. PubMed ID: 3873711
    [No Abstract]   [Full Text] [Related]  

  • 28. Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder.
    Kim YK; Jung HG; Myint AM; Kim H; Park SH
    J Affect Disord; 2007 Dec; 104(1-3):91-5. PubMed ID: 17434599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody-based therapies in systemic lupus erythematosus.
    Iikuni N; La Cava A
    Mini Rev Med Chem; 2009 Jun; 9(7):829-46. PubMed ID: 19519508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune system under assault in Massachusetts.
    Umlauf SW; Ryan US
    Nat Biotechnol; 1996 Jul; 14(7):830. PubMed ID: 9631004
    [No Abstract]   [Full Text] [Related]  

  • 31. Interleukin-10 response abnormalities in systemic lupus erythematosus.
    Mongan AE; Ramdahin S; Warrington RJ
    Scand J Immunol; 1997 Oct; 46(4):406-12. PubMed ID: 9350293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarkers in systemic lupus erythematosus: II. Markers of disease activity.
    Illei GG; Tackey E; Lapteva L; Lipsky PE
    Arthritis Rheum; 2004 Jul; 50(7):2048-65. PubMed ID: 15248202
    [No Abstract]   [Full Text] [Related]  

  • 33. NF-κB and systemic lupus erythematosus: examining the link.
    Zubair A; Frieri M
    J Nephrol; 2013; 26(6):953-9. PubMed ID: 23807646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical significance of decreased T cell interleukin-2 production in systemic lupus erythematosus: connecting historical dots.
    Horwitz DA
    Arthritis Rheum; 2010 Aug; 62(8):2185-7. PubMed ID: 20506258
    [No Abstract]   [Full Text] [Related]  

  • 35. [Physiopathology of systemic lupus erythematosus: a 2014 update].
    Mathian A; Arnaud L; Amoura Z
    Rev Med Interne; 2014 Aug; 35(8):503-11. PubMed ID: 24262408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokines play a central role in the pathogenesis of systemic lupus erythematosus.
    Singh AK
    Med Hypotheses; 1992 Dec; 39(4):356-9. PubMed ID: 1494323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mechanisms of lymphocyte activation in systemic lupus erythematosus].
    Gaspar ML; Alvarez Mon M; Gutiérrez C
    Med Clin (Barc); 1986 Feb; 86(4):175. PubMed ID: 3486333
    [No Abstract]   [Full Text] [Related]  

  • 38. Cytokines in systemic lupus erythematosus, London, UK.
    Rahman A
    Arthritis Res Ther; 2003; 5(4):160-4. PubMed ID: 12823845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal stem cells promote CD206 expression and phagocytic activity of macrophages through IL-6 in systemic lupus erythematosus.
    Deng W; Chen W; Zhang Z; Huang S; Kong W; Sun Y; Tang X; Yao G; Feng X; Chen W; Sun L
    Clin Immunol; 2015 Dec; 161(2):209-16. PubMed ID: 26209923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of T lymphocytes in systemic lupus erythematosus].
    Zubler RH; Miescher PA
    Ann Med Interne (Paris); 1990; 141(3):208-12. PubMed ID: 2195945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.